InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-38.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Civik Thomas, Director. Officer active across 2 companies, notably Repare Therapeutics Inc.. In total, 5 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €362k. Activity tracked since 16 November 2021. The latest transaction was filed on 24 March 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
7,500 sharesCommon SharesSEC:0001723092-26-000002:0
139,355 shares0Common StockSEC:0001209191-23-021404:0
66,831 shares0Common StockSEC:0001140361-22-012919:0
15,700 shares@ US$12.740.12% mcap50.0% of flowCommon StockSEC:0000899243-21-045363:0
Ideal exit: 15 Aug 2022 (T+270)
7,500 shares@ US$28.0850.0% of flowCommon SharesSEC:0001209191-21-065517:0
Ideal exit: 13 Aug 2022 (T+270)
5 of 5 declarations
About Civik Thomas
Thomas Civik is a Director at Repare Therapeutics Inc. and Pyxis Oncology, Inc. He brings his biotechnology expertise to the board, participating in strategic decision-making for the company. His experience is essential in guiding innovation.
